Kantonsspital Winterthur
Winterthur, Switzerland
29 recruiting
Showing 1–20 of 52 trials
Recruiting
Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled555 locationsNCT06492616
Recruiting
Not Applicable
Hyperoxia During Outpatient Pulmonary Rehabilitation in Chronic Lung Disease - Does it Matter?
Chronic Obstructive Pulmonary Disease (COPD)
Eastern Switzerland University of Applied Sciences32 enrolled1 locationNCT06776731
Recruiting
Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Carcinoma, Non-Small Cell LungNeoplasm Metastasis
Eli Lilly and Company1,264 enrolled419 locationsNCT06119581
Recruiting
Phase 2
Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC
NSCLCNSCLC (Advanced Non-small Cell Lung Cancer)
Swiss Cancer Institute47 enrolledNCT07158489
Recruiting
Phase 3
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Multiple Myeloma
Pfizer1,116 enrolled127 locationsNCT05623020
Recruiting
Phase 2
Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma
Oropharynx Cancer
University of Zurich120 enrolled6 locationsNCT06563362
Recruiting
Phase 2
Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
Triple-Negative Breast CancerTNBC - Triple-Negative Breast Cancer
Swiss Cancer Institute61 enrolled9 locationsNCT06358573
Recruiting
Phase 3
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Prostate CancerCancer of the ProstateHormone Sensitive Prostate Cancer+1 more
Pfizer1,000 enrolled341 locationsNCT07028853
Recruiting
Not Applicable
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Breast Cancer
University Hospital, Basel, Switzerland1,060 enrolled54 locationsNCT07140172
Recruiting
Phase 2
Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
Recurrent Prostate Cancer
Swiss Cancer Institute42 enrolled11 locationsNCT07365423
Recruiting
Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
Metastatic Colorectal CancerBRAF V600E Mutation
Swiss Cancer Institute30 enrolled13 locationsNCT07617610
Recruiting
Phase 2Phase 3
Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)
Metastatic NSCLC - Non-Small Cell Lung Cancer
Swiss Cancer Institute230 enrolled11 locationsNCT07149649
Recruiting
LUCINAE Registry: Thoracic Cancers During Pregnancy
Lung CancerThoracic CancerCancer During Pregnancy
Oncology Institute of Southern Switzerland100 enrolled4 locationsNCT07699861
Recruiting
Phase 3
A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy
Non-small Cell Lung Cancer
ETOP IBCSG Partners Foundation390 enrolled35 locationsNCT06931717
Recruiting
Phase 2
Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Metastatic Castration-resistant Prostate Cancer
Swiss Cancer Institute162 enrolled13 locationsNCT06401980
Recruiting
Phase 1
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Extensive-stage Small-cell Lung Cancer
Amgen220 enrolled31 locationsNCT06598306
Recruiting
Modeling and Workflow Recognition for the Anterior Approach in Total Hip Arthroplasty
Hip Prosthesis
Philipp Fürnstahl60 enrolled3 locationsNCT05993845
Recruiting
Not Applicable
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
Lymphedema, Breast Cancer
University Hospital, Basel, Switzerland280 enrolled36 locationsNCT05890677
Recruiting
Phase 3
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
Oligometastatic Squamous Cell Carcinoma of the Head and Neck
European Organisation for Research and Treatment of Cancer - EORTC200 enrolled30 locationsNCT05815927
Recruiting
Phase 2
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
SCLC,Extensive StageSLFN11-positive
ETOP IBCSG Partners Foundation44 enrolled18 locationsNCT05718323